http://en.wikipedia.org/wiki/P110α

This gene's product is P110α (The phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) is a class I PI 3-kinase catalytic subunit which uses ATP to phosphorylate phosphatidylinositols (PtdIns), PtdIns4P and PtdIns(4,5)P2.

Cancer 세포에서 이 유전자의 변이가 많이 발견됨. 약물타겟으로도 많이 연구됨.

변이별 처방

1. E542K, E545K, H104Y: Herceptin 치료예후가 좋은 것으로 알려져 있지만, HER2 유전자 증폭과 더불어 PICK3CA 돌연변이를 가질 경우 내성을 가진다고 알려짐

Incoming Links #

Related Articles (Article 0) #

• ConSig
• Lung cancer
• Metastasis
• PI3K
• Personalized medicine

Related Medical Scholarly Articles (MedicalScholarlyArticle 1) #

• Comprehensive molecular portraits of human breast tumours
• Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
• Landscape of somatic mutations in 560 breast cancer whole-genome sequences
• Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
• The cancer genome

Suggested Pages #

• 0.135 Neoplasm
• 0.106 Cell-free tumor DNA
• 0.066 TP53
• 0.061 CDH1
• 0.060 Heparan sulfate
• 0.034 Receptor tyrosine kinase
• 0.032 mTOR
• 0.031 Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers
• 0.025 An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer
• 0.024 2016
• More suggestions...